Elsevier

The Lancet Rheumatology

Volume 4, Issue 1, January 2022, Pages e13-e16
The Lancet Rheumatology

Comment
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab

https://doi.org/10.1016/S2665-9913(21)00351-9Get rights and content

Cited by (0)

View Abstract